Literature DB >> 30711544

The protective effect of high mobility group protein HMGA2 in pressure overload-induced cardiac remodeling.

Qing-Qing Wu1, Yang Xiao1, Chen Liu1, Mingxia Duan1, Zhulan Cai1, Saiyang Xie1, Yuan Yuan1, Haiming Wu1, Wei Deng1, Qizhu Tang2.   

Abstract

High mobility group protein AT-hook 2 (HMGA2), an architectural transcription factor, has previously been reported to play an essential role in regulating the expression of many genes through architectural remodeling processes. However, the effects of HMGA2 on cardiovascular disease, especial cardiac remodeling, is unclear. This study was aimed at investigating the functional role of HMGA2 in pressure overload-induced cardiac remodeling. Mice that were subjected to aortic banding (AB) for 8 weeks developed myocardial hypertrophy and cardiac dysfunction, which were associated with altered expression of HMGA2. Cardiac-specific expression of the human HMGA2 gene in mice with an adeno-related virus 9 delivery system ameliorated cardiac remodeling and improve cardiac function in response to pressure overload by activating PPARγ/NRF2 signaling. Knockdown of HMGA2 by AAV9-shHMGA2 accelerated cardiac remodeling after 1 weeks of AB surgery. Additionally, knockdown of heart PPARγ largely abolished HMGA2 overexpression-mediated cardioprotection. HMGA2-mediated cardiomyocyte protection was largely abrogated by knocking down NRF2 and inhibiting PPARγ in cardiomyocytes. PPARγ activation was mediated by C/EBPβ, which directly interacted with HMGA2. Knocking down C/EBPβ offset the effects of HMGA2 on PPARγ activation and cardioprotection. These findings show that the overexpression of HMGA2 ameliorates the remodeling response to pressure overload, and they also imply that the upregulation of HMGA2 may become a treatment strategy in cardiac pathologies.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  C/EBPβ; Cardiac remodeling; HMGA2; NRF2; PPARγ

Mesh:

Substances:

Year:  2019        PMID: 30711544     DOI: 10.1016/j.yjmcc.2019.01.027

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  9 in total

1.  Nobiletin Attenuates Pathological Cardiac Remodeling after Myocardial Infarction via Activating PPARγ and PGC1α.

Authors:  Yufei Zhou; Ting Yin; Mengsha Shi; Mengli Chen; Xiaodong Wu; Kai Wang; Iokfai Cheang; Yanxiu Li; Hongcai Shang; Haifeng Zhang; Xinli Li
Journal:  PPAR Res       Date:  2021-08-06       Impact factor: 4.964

2.  Genetic Determinants of Electrocardiographic P-Wave Duration and Relation to Atrial Fibrillation.

Authors:  Lu-Chen Weng; Amelia Weber Hall; Seung Hoan Choi; Sean J Jurgens; Jeffrey Haessler; Nathan A Bihlmeyer; Niels Grarup; Honghuang Lin; Alexander Teumer; Ruifang Li-Gao; Jie Yao; Xiuqing Guo; Jennifer A Brody; Martina Müller-Nurasyid; Katharina Schramm; Niek Verweij; Marten E van den Berg; Jessica van Setten; Aaron Isaacs; Julia Ramírez; Helen R Warren; Sandosh Padmanabhan; Jan A Kors; Rudolf A de Boer; Peter van der Meer; Moritz F Sinner; Melanie Waldenberger; Bruce M Psaty; Kent D Taylor; Uwe Völker; Jørgen K Kanters; Man Li; Alvaro Alonso; Marco V Perez; Ilonca Vaartjes; Michiel L Bots; Paul L Huang; Susan R Heckbert; Henry J Lin; Jelena Kornej; Patricia B Munroe; Cornelia M van Duijn; Folkert W Asselbergs; Bruno H Stricker; Pim van der Harst; Stefan Kääb; Annette Peters; Nona Sotoodehnia; Jerome I Rotter; Dennis O Mook-Kanamori; Marcus Dörr; Stephan B Felix; Allan Linneberg; Torben Hansen; Dan E Arking; Charles Kooperberg; Emelia J Benjamin; Kathryn L Lunetta; Patrick T Ellinor; Steven A Lubitz
Journal:  Circ Genom Precis Med       Date:  2020-08-21

3.  The pro-migration and anti-apoptosis effects of HMGA2 in HUVECs stimulated by hypoxia.

Authors:  Zhu-Lan Cai; Chen Liu; Qi Yao; Qing-We Xie; Tong-Tong Hu; Qing-Qing Wu; Qi-Zhu Tang
Journal:  Cell Cycle       Date:  2020-12-14       Impact factor: 4.534

Review 4.  A review of the tortuous path of nonviral gene delivery and recent progress.

Authors:  Divya Sharma; Sanjay Arora; Jagdish Singh; Buddhadev Layek
Journal:  Int J Biol Macromol       Date:  2021-06-01       Impact factor: 8.025

5.  Role of GALNT4 in protecting against cardiac hypertrophy through ASK1 signaling pathway.

Authors:  Bin-Bin Zhang; Lu Gao; Qin Yang; Yuan Liu; Xiao-Yue Yu; Ji-Hong Shen; Wen-Cai Zhang; Zhan-Ying Han; Shao-Ze Chen; Sen Guo
Journal:  Cell Death Dis       Date:  2021-10-22       Impact factor: 8.469

6.  STING protects against cardiac dysfunction and remodelling by blocking autophagy.

Authors:  Rui Xiong; Ning Li; Lei Chen; Wei Wang; Bo Wang; Wenyang Jiang; Qing Geng
Journal:  Cell Commun Signal       Date:  2021-11-08       Impact factor: 5.712

7.  EZH2 mitigates the cardioprotective effects of mesenchymal stem cell-secreted exosomes against infarction via HMGA2-mediated PI3K/AKT signaling.

Authors:  Wei Jiao; Jie Hao; Yanan Xie; Mingjie Meng; Weinian Gao
Journal:  BMC Cardiovasc Disord       Date:  2022-03-09       Impact factor: 2.298

8.  Tumor Necrosis Factor-α-Induced Protein 8-Like 2 Ameliorates Cardiac Hypertrophy by Targeting TLR4 in Macrophages.

Authors:  Rui Yao; Lingyao Kong; Chunlei Yang; Jiaqi Du; Guojun Zhao; Yapeng Li
Journal:  Oxid Med Cell Longev       Date:  2022-04-26       Impact factor: 7.310

9.  The effect of HMGA1 in LPS-induced Myocardial Inflammation.

Authors:  Zhu-Lan Cai; Bo Shen; Yuan Yuan; Chen Liu; Qing-Wen Xie; Tong-Tong Hu; Qi Yao; Qing-Qing Wu; Qi-Zhu Tang
Journal:  Int J Biol Sci       Date:  2020-03-26       Impact factor: 6.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.